Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.

Zanchi C, Macconi D, Trionfini P, Tomasoni S, Rottoli D, Locatelli M, Rudnicki M, Vandesompele J, Mestdagh P, Remuzzi G, Benigni A, Zoja C.

Diabetologia. 2017 Jun;60(6):1114-1125. doi: 10.1007/s00125-017-4248-9. Epub 2017 Mar 31.

2.

Mitochondrial Dynamics Is Linked to Longevity and Protects from End-Organ Injury: The Emerging Role of Sirtuin 3.

Benigni A, Perico L, Macconi D.

Antioxid Redox Signal. 2016 Aug 1;25(4):185-99. doi: 10.1089/ars.2016.6682. Epub 2016 Apr 19. Review.

PMID:
26972664
3.

Key fibrogenic mediators: old players. Renin-angiotensin system.

Macconi D, Remuzzi G, Benigni A.

Kidney Int Suppl (2011). 2014 Nov;4(1):58-64. Review.

4.

Regression of Renal Disease by Angiotensin II Antagonism Is Caused by Regeneration of Kidney Vasculature.

Remuzzi A, Sangalli F, Macconi D, Tomasoni S, Cattaneo I, Rizzo P, Bonandrini B, Bresciani E, Longaretti L, Gagliardini E, Conti S, Benigni A, Remuzzi G.

J Am Soc Nephrol. 2016 Mar;27(3):699-705. doi: 10.1681/ASN.2014100971. Epub 2015 Jun 26.

5.

Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II.

Macconi D, Perico L, Longaretti L, Morigi M, Cassis P, Buelli S, Perico N, Remuzzi G, Benigni A.

PLoS One. 2015 May 19;10(5):e0127172. doi: 10.1371/journal.pone.0127172. eCollection 2015.

6.

Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway.

Gagliardini E, Perico N, Rizzo P, Buelli S, Longaretti L, Perico L, Tomasoni S, Zoja C, Macconi D, Morigi M, Remuzzi G, Benigni A.

Am J Pathol. 2013 Jul;183(1):119-30. doi: 10.1016/j.ajpath.2013.03.025. Epub 2013 May 23.

7.

MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition.

Macconi D, Tomasoni S, Romagnani P, Trionfini P, Sangalli F, Mazzinghi B, Rizzo P, Lazzeri E, Abbate M, Remuzzi G, Benigni A.

J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.

8.

Targeting the renin angiotensin system for remission/regression of chronic kidney disease.

Macconi D.

Histol Histopathol. 2010 May;25(5):655-68. doi: 10.14670/HH-25.655. Review.

PMID:
20238303
9.

Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.

Macconi D, Sangalli F, Bonomelli M, Conti S, Condorelli L, Gagliardini E, Remuzzi G, Remuzzi A.

Am J Pathol. 2009 Mar;174(3):797-807. doi: 10.2353/ajpath.2009.080227. Epub 2009 Jan 22.

10.

Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides.

Macconi D, Chiabrando C, Schiarea S, Aiello S, Cassis L, Gagliardini E, Noris M, Buelli S, Zoja C, Corna D, Mele C, Fanelli R, Remuzzi G, Benigni A.

J Am Soc Nephrol. 2009 Jan;20(1):123-30. doi: 10.1681/ASN.2007111233. Epub 2008 Dec 17.

11.

Candesartan and renal protection: more than blocking angiotensin type 1 receptor?

Macconi D, Remuzzi G.

Kidney Int. 2008 Nov;74(9):1112-4. doi: 10.1038/ki.2008.420. Review.

12.

Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.

Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, Moioli D, Remuzzi G, Zoja C.

Am J Pathol. 2006 Dec;169(6):1965-75.

13.

Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.

Macconi D, Abbate M, Morigi M, Angioletti S, Mister M, Buelli S, Bonomelli M, Mundel P, Endlich K, Remuzzi A, Remuzzi G.

Am J Pathol. 2006 Apr;168(4):1073-85.

14.

Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.

Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A.

Am J Pathol. 2006 Jan;168(1):42-54.

15.

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies.

Ruiz-Torres MP, Casiraghi F, Galbusera M, Macconi D, Gastoldi S, Todeschini M, Porrati F, Belotti D, Pogliani EM, Noris M, Remuzzi G.

Thromb Haemost. 2005 Mar;93(3):443-52.

PMID:
15735793
16.

Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.

Galbusera M, Buelli S, Gastoldi S, Macconi D, Angioletti S, Testa C, Remuzzi G, Morigi M.

Xenotransplantation. 2005 Mar;12(2):110-20.

PMID:
15693841
17.

Nitric oxide synthetic capacity in relation to dialysate temperature.

Beerenhout CH, Noris M, Kooman JP, Porrati F, Binda E, Morigi M, Bekers O, van der Sande FM, Todeschini M, Macconi D, Leunissen KM, Remuzzi G.

Blood Purif. 2004;22(2):203-9.

PMID:
15044819
18.

L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species.

Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo C, Remuzzi G.

Hypertension. 2004 Mar;43(3):614-22. Epub 2004 Jan 26.

PMID:
14744923
19.

[Mechanisms of endothelial damage in thrombotic microangiopathy].

Ruiz-Torres MP, Casighari F, Noris M, Macconi D, Galbusera M, Remuzzi G.

Nefrologia. 2003;23 Suppl 3:25-7. Review. Spanish. No abstract available.

20.

Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation.

Todeschini M, Macconi D, Fernández NG, Ghilardi M, Anabaya A, Binda E, Morigi M, Cattaneo D, Perticucci E, Remuzzi G, Noris M.

Am J Kidney Dis. 2002 Oct;40(4):783-93.

PMID:
12324914
21.

Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway.

Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, Ghilardi M, Remuzzi G.

J Am Soc Nephrol. 2002 May;13(5):1179-89.

22.

Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats.

Macconi D, Ghilardi M, Bonassi ME, Mohamed EI, Abbate M, Colombi F, Remuzzi G, Remuzzi A.

J Am Soc Nephrol. 2000 Mar;11(3):477-89.

23.

Selective dietary restriction of protein and calorie intakes prevents spontaneous proteinuria in male MWF rats.

Macconi D, Laurens W, Paris S, Battaglia C, Bertani T, Remuzzi G, Remuzzi A.

Exp Nephrol. 1997 Sep-Oct;5(5):404-13.

PMID:
9386977
24.

Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury.

Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G.

Am J Kidney Dis. 1996 Jun;27(6):790-6.

PMID:
8651242
25.

PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress.

Macconi D, Foppolo M, Paris S, Noris M, Aiello S, Remuzzi G, Remuzzi A.

Am J Physiol. 1995 Jul;269(1 Pt 1):C42-7.

PMID:
7631759
26.

Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.

Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G.

Am J Physiol. 1994 Dec;267(6 Pt 2):F1034-44.

PMID:
7528985
27.

Defective glomerular [3H]lysoPAF metabolism in the autologous phase of rabbit nephrotoxic nephritis.

Noris M, Macconi D, Nanni V, Salmona M, Todeschini M, Remuzzi G.

Kidney Int. 1993 Oct;44(4):747-54.

28.

Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitides.

Macconi D, Zanoli AF, Orisio S, Longaretti L, Magrini L, Rota S, Radice A, Pozzi C, Remuzzi G.

Kidney Int. 1993 Jul;44(1):215-20.

29.

Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury.

Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G.

Lab Invest. 1992 Nov;67(5):572-9.

PMID:
1434536
30.

Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation.

Macconi D, Viganò G, Bisogno G, Galbusera M, Orisio S, Remuzzi G, Livio M.

Am J Kidney Dis. 1992 Apr;19(4):318-25.

PMID:
1562019
31.

Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice.

Morigi M, Macconi D, Riccardi E, Boccardo P, Zilio P, Bertani T, Remuzzi G.

J Pharmacol Exp Ther. 1991 Aug;258(2):601-6.

PMID:
1650836
32.

Increased urinary excretion of platelet activating factor in mice with lupus nephritis.

Macconi D, Noris M, Benfenati E, Quaglia R, Pagliarino G, Remuzzi G.

Life Sci. 1991;48(15):1429-37.

PMID:
2011046
33.

Renal metabolism and urinary excretion of platelet-activating factor in the rat.

Noris M, Perico N, Macconi D, Nanni V, Dadan J, Peterlongo F, Remuzzi G.

J Biol Chem. 1990 Nov 15;265(32):19414-9.

34.

Role of endothelium-derived nitric oxide in the bleeding tendency of uremia.

Remuzzi G, Perico N, Zoja C, Corna D, Macconi D, Viganò G.

J Clin Invest. 1990 Nov;86(5):1768-71.

35.

Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis.

Zoja C, Corna D, Macconi D, Zilio P, Bertani T, Remuzzi G.

Lab Invest. 1990 Jan;62(1):34-40.

PMID:
1688634
36.

Development of a mass spectrometric method to quantitate platelet activating factor in mouse urine.

Benfenati E, Macconi D, Noris M, Icardi G, Bettazzoli L, De Bellis G, Gavinelli M, Rotondo S, Remuzzi G.

J Lipid Res. 1989 Dec;30(12):1977-81.

37.

Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.

Macconi D, Benigni A, Morigi M, Ubiali A, Orisio S, Livio M, Perico N, Bertani T, Remuzzi G, Patrono C.

J Lab Clin Med. 1989 May;113(5):549-60.

PMID:
2541212
38.

Metabolism of arachidonic acid in isolated glomeruli from pig kidney.

Livio M, Chiabrando C, Macconi D, Benigni A, Zimei M, De Pietro MT, Remuzzi G.

Biochim Biophys Acta. 1988 Jul 1;961(1):110-21.

PMID:
3132983
39.

Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis.

Bertani T, Livio M, Macconi D, Morigi M, Bisogno G, Patrono C, Remuzzi G.

Kidney Int. 1987 Jun;31(6):1248-56.

40.

A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.

Livio M, Macconi D, Morigi M, Orisio S, Benigni A, Patrono C, Remuzzi G.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:828-32. No abstract available.

PMID:
2823570
41.

Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.

Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.

Lab Invest. 1985 Feb;52(2):159-68.

PMID:
3155816
43.

The inhibitory effect of methylenedisalicylic acid on the attachment of ribosomes to microsomal membranes in vitro.

Aporti G, Schiatti A, Macconi D, Borgese N.

FEBS Lett. 1980 Jul 11;116(1):95-8. No abstract available.

44.

Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.

De Camilli P, Macconi D, Spada A.

Nature. 1979 Mar 15;278(5701):252-4. No abstract available.

PMID:
423973

Supplemental Content

Loading ...
Support Center